Candidemia Surveillance Publications

Candidemia Surveillance Publications
Arthington-Skaggs, B. A., W. Lee-Yang, M. A. Ciblak, J. P. Frade, M. E. Brandt, R. A. Hajjeh, L. H.
Harrison, A. N. Sofair, D. W. Warnock and G. Candidemia Active Surveillance (2002).
"Comparison of visual and spectrophotometric methods of broth microdilution MIC end
point determination and evaluation of a sterol quantitation method for in vitro
susceptibility testing of fluconazole and itraconazole against trailing and nontrailing
Candida isolates." Antimicrobial Agents & Chemotherapy 46(8): 2477-2481.
Brandt, M. E., L. H. Harrison, M. Pass, A. N. Sofair, S. Huie, R. K. Li, C. J. Morrison, D. W.
Warnock and R. A. Hajjeh (2000). "Candida dubliniensis fungemia: the first four cases in
North America." Emerging Infectious Diseases 6(1): 46-49.
Hajjeh, R. A., A. N. Sofair, L. H. Harrison, G. M. Lyon, B. A. Arthington-Skaggs, S. A. Mirza, M.
Phelan, J. Morgan, W. Lee-Yang, M. A. Ciblak, L. E. Benjamin, L. T. Sanza, S. Huie, S. F.
Yeo, M. E. Brandt and D. W. Warnock (2004). "Incidence of bloodstream infections due
to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in
a population-based active surveillance program." Journal of Clinical Microbiology 42(4):
Lott, T. J., R. E. Fundyga, M. E. Brandt, L. H. Harrison, A. N. Sofair, R. A. Hajjeh and D. W.
Warnock (2003). "Stability of allelic frequencies and distributions of Candida albicans
microsatellite loci from U.S. population-based surveillance isolates." Journal of Clinical
Microbiology 41(3): 1316-1321.
Morgan, J., M. I. Meltzer, B. D. Plikaytis, A. N. Sofair, S. Huie-White, S. Wilcox, L. H. Harrison, E.
C. Seaberg, R. A. Hajjeh and S. M. Teutsch (2005). "Excess mortality, hospital stay, and
cost due to candidemia: a case-control study using data from population-based
candidemia surveillance.[Erratum appears in Infect Control Hosp Epidemiol. 2005
Aug;26(8):675]." Infection Control & Hospital Epidemiology 26(6): 540-547.
Park, B. J., B. A. Arthington-Skaggs, R. A. Hajjeh, N. Iqbal, M. A. Ciblak, W. Lee-Yang, M. D.
Hairston, M. Phelan, B. D. Plikaytis, A. N. Sofair, L. H. Harrison, S. K. Fridkin and D. W.
Warnock (2006). "Evaluation of amphotericin B interpretive breakpoints for Candida
bloodstream isolates by correlation with therapeutic outcome." Antimicrobial Agents &
Chemotherapy 50(4): 1287-1292.
Smith, P. B., J. Morgan, J. D. Benjamin, S. K. Fridkin, L. T. Sanza, L. H. Harrison, A. N. Sofair, S.
Huie-White and D. K. Benjamin, Jr. (2007). "Excess costs of hospital care associated with
neonatal candidemia." Pediatric Infectious Disease Journal 26(3): 197-200.
Sofair, A. N., G. M. Lyon, S. Huie-White, E. Reiss, L. H. Harrison, L. T. Sanza, B. A. ArthingtonSkaggs and S. K. Fridkin (2006). "Epidemiology of community-onset candidemia in
Connecticut and Maryland." Clinical Infectious Diseases 43(1): 32-39.
Yeo, S. F., S. Huie, A. N. Sofair, S. Campbell, A. Durante and B. Wong (2006). "Measurement of
serum D-arabinitol/creatinine ratios for initial diagnosis and for predicting outcome in
an unselected, population-based sample of patients with Candida fungemia." Journal of
Clinical Microbiology 44(11): 3894-3899.